急性疼痛服务利用区域麻醉技术降低丁丙诺啡/纳洛酮启动障碍
本病例报告描述一名C4不完全性四肢瘫痪合并阿片类药物使用障碍及严重腹部痉挛的患者,因腹部痉挛疼痛导致丁丙诺啡/纳洛酮启动失败。急性疼痛服务团队采用超声引导下腹部肌肉化学去神经术(肉毒毒素A注射)缓解痉挛后,成功完成丁丙诺啡/纳洛酮启动。启动后6个月患者仍坚持丁丙诺啡/纳洛酮8 mg/2 mg每日三次,未使用非处方阿片类药物。
要点
- 急性疼痛服务可主导住院患者丁丙诺啡/纳洛酮启动。
- 超声引导下肉毒毒素A注射可缓解腹部痉挛,消除启动障碍。
- 急性疼痛服务具备超声引导介入等独特技能,可个体化处理复杂阿片类药物使用障碍患者。
核心结论
- 急性疼痛服务主导的住院丁丙诺啡/纳洛酮启动可通过解决启动障碍提高治疗成功率。
- 急性疼痛服务临床医生具备超声引导介入等独特技能和知识,能为复杂阿片类药物使用障碍患者提供创新和个体化治疗。
研究设计与样本
- 病例报告:一名C4不完全性四肢瘫痪合并阿片类药物使用障碍及腹部痉挛的患者。
主要发现
- 患者因腹部痉挛所致疼痛加重而开始出现丁丙诺啡/纳洛酮启动失败。
- 给予超声引导下腹部肌肉化学去神经术(肉毒毒素A注射)后腹部痉挛缓解,并成功完成丁丙诺啡/纳洛酮启动。
- 启动后6个月,患者仍坚持丁丙诺啡/纳洛酮8 mg/2 mg每日三次,未使用非处方阿片类药物。
临床怎么用
- 对因痉挛疼痛导致丁丙诺啡/纳洛酮启动失败的患者,可考虑由急性疼痛服务采用超声引导下肉毒毒素A注射等区域麻醉技术解除障碍。
局限性
- 本文为单例病例报告,结论不能推广至所有阿片类药物使用障碍患者。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Medications for opioid use disorder (MOUD) are a life-saving intervention; thus, it is important to address barriers to successful initiation. Spasticity affects many patients with spinal cord injury and can be painful and physically debilitating. Chronic painful conditions can lead to the illicit use of non-prescribed opioids, but fear of pain is a barrier to the initiation of MOUD. In this case report, we describe the novel use of botulinum toxin A injections to treat abdominal spasticity and facilitate Acute Pain Service-led buprenorphine/naloxone initiation in a patient with opioid use disorder and severe abdominal spasticity due to spinal cord injury. CASE PRESENTATION: A patient with C4 incomplete tetraplegia and opioid use disorder complicated by abdominal spasticity refractory to oral antispasmodics and self-treating with intravenous heroin was referred to the Acute Pain Service for inpatient buprenorphine/naloxone initiation. The patient began to fail initiation of buprenorphine/naloxone secondary to increased pain from abdominal spasms. The patient was offered ultrasound-guided abdominal muscle chemodenervation with botulinum toxin A, which resulted in the resolution of abdominal spasticity and facilitated successful buprenorphine/naloxone initiation. At 6 months post-initiation, the patient remained abstinent from non-prescribed opioids and compliant with buprenorphine/naloxone 8 mg/2 mg three times a day. CONCLUSIONS: This case report demonstrates that inpatient buprenorphine/naloxone initiation by an Acute Pain Service can improve the success of treatment by addressing barriers to initiation. Acute Pain Service clinicians possess unique skills and knowledge, including ultrasound-guided interventions, that enable them to provide innovative and personalized approaches to care in the complex opioid use disorder population.
引用
- Seol A, Chan J, Micham B, et al. Acute pain service reduces barriers to buprenorphine/naloxone initiation by using regional anesthesia techniques. Reg Anesth Pain Med. 2023. PMID: 36792313. doi:10.1136/rapm-2022-104317
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。